Background—
Platelet aggregation plays a critical role in myocardial infarction and stroke; however, the role of platelet secretion in atherosclerotic vascular disease is poorly understood. Therefore, we examined the hypothesis that platelet dense-granule secretion modulates thrombosis, inflammation, and atherosclerotic vascular remodeling after injury.
Methods and Results—
Functional deletion of the Hermansky-Pudlak syndrome 3 gene (HPS3
−/−
) markedly reduces platelet dense-granule secretion. HPS3
−/−
mice have normal platelet counts, platelet morphology, and α-granule number, as well as maximal secretion of the α-granule marker P-selectin; however, their capacity to form platelet-leukocyte aggregates is significantly reduced (
P
<0.05). To examine the role of platelet dense-granule secretion in these processes, atherosclerosis-prone mice with combined genetic deficiency of apolipoprotein E and HPS3 (ApoE
−/−
, HPS3
−/−
) were compared with congenic, atherosclerosis-prone mice with normal platelet secretion (ApoE
−/−
, HPS3
+/+
). After 16 to 18 weeks on a high-fat diet, both groups of mice had similar fasting cholesterol levels and body weight. Carotid arteries of ApoE
−/−
, HPS3
+/+
mice thrombosed rapidly after FeCl
3
injury, but ApoE
−/−
, HPS3
−/−
mice were completely resistant to thrombotic arterial occlusion (
P
<0.01). Three weeks after injury, neointimal hyperplasia (from α-smooth muscle actin–positive cells) was significantly less (
P
<0.001) in arteries from ApoE
−/−
, HPS3
−/−
mice. In ApoE
−/−
, HPS3
−/−
mice, there were also pronounced reductions in arterial inflammation, as indicated by a 74% decrease in CD45-positive leukocytes (
P
<0.01) and a 73% decrease in Mac-3–positive macrophages (
P
<0.05).
Conclusions—
In atherosclerotic mice, reduced platelet dense-granule secretion is associated with marked protection against the development of arterial thrombosis, inflammation, and neointimal hyperplasia after vascular injury.